pyrazinamide has been researched along with Idiopathic Parkinson Disease in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawachi, M | 1 |
| Kono, N | 1 |
| Kiyokawa, H | 1 |
| Mineo, I | 1 |
| Nakajima, H | 1 |
| Shimizu, T | 1 |
| Yorifuji, S | 1 |
| Kuwajima, M | 1 |
| Tarui, S | 1 |
1 other study available for pyrazinamide and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Decreased renal clearance of xanthine and hypoxanthine in a patient with renal hypouricemia: a new defect in renal handling of purines.
Topics: Humans; Hypoxanthine; Hypoxanthines; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; P | 1992 |